Merck KGaA’s antibody-drug conjugate (ADC), precemtabart tocentecan, has shown to be safe and tolerable in a Phase Ib trial.

Merck KGaA (Merck) is filing for global regulatory approvals of its CSF-1R inhibitor pimicotinib after it met the primary and ...

German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more cautiously for 2025 earnings, citing foreign-exchange effects and uncertainty over tariffs.

This week's dividend activity included increased payouts from BMO Financial (BMO) and Royal Bank of Canada (RY) as well as ...

Officially called Merck Wilmington Biotech ... which earlier this year received a $30.2-million grant from Delaware’s Council of Development Finance. The company’s presentation to the agency ...

First, it was Panasonic. Now, another major company is planting deeper roots in De Soto. Merck Animal Health has announced an expansion of its De Soto operations, and it’s bringing hundreds of ...

Germany’s Merck KGaA (MRK: DE) today announced the presentation of detailed positive results from Part 1 of the global Phase ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

Merck Animal Health, a unit of Merck , said on Thursday it would invest $895 million to expand its manufacturing facility in ...

Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future medicines to market.

The State of Kansas announced an $895 million capital expansion project at the Merck Animal Health manufacturing facility in ...

KANSAS CITY, Mo. — The animal health division of global pharmaceutical company Merck is doubling down on its operations in De Soto. Merck Animal Health, along with local, regional and state ...